Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Sanofi
02 1Biocon
03 1Biocon Biologics
04 2Biosimilar Collaborations Ireland Limited
05 91Novo Nordisk
01 4CAT
02 1Flextouch Injectable Solution In Pre-Filled Pen
03 1INJ
04 10INJECTABLE;SUBCUTANEOUS
05 3INJECTION;SOLUTION
06 9Injectable Solution
07 1Injectable Solution In A Pre-Filled Pen
08 2Injectable Solution In Cartridge
09 1Injectable Solution In Pre-Filled Pen
10 2Injectable Solution In Vial
11 3Injection
12 1Injection fluid, resolution
13 1Injection fluid, resolution in sylinderampulle
14 1Injection fluid, resolution in the finished filled pen
15 1Injection fluid, resolution in the hood glass
16 2Injection fluid, suspension
17 1Insulin Aspart 160U 1,6Ml 5 Units Parenteral Use
18 2Insulin Aspart 300Iu 3Ml 5 Units Parenteral Use
19 3PED
20 2PFP
21 1Penfill Injectable Solution In Cartridge
22 1Pumpcart Injectable Solution In Cartridge
23 9SOLUTION
24 1SOLUTION;INTRAVENOUS, SUBCUTANEOUS
25 3SOLUTION;SUBCUTANEOUS
26 2SUSPENSION
27 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 30/70 300Iu 3Ml 5 Units Parenteral Use
28 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 50/50 300Iu 3Ml 5 Units Parenteral Use
29 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 70/30 300Iu 3Ml 5 Units Parenteral Use
30 25Solution For Injection
31 5Suspension For Injection
32 4Blank
01 11Allowed
02 22Approved
03 9Authorized
04 6Deregistered
05 10Originator
06 11Schedule D
07 36Blank
01 4FIASP
02 1FIASP FLEXTOUCH
03 1FIASP PENFILL
04 9Fiasp
05 1Fiasp Eml ultra-fast-acting PumpCart
06 1Fiasp Penfill
07 1Fiasp Pumpcart
08 1Fiasp ultra-fast-acting
09 1Fiasp ultra-fast-acting FlexTouch
10 1Fiasp ultra-fast-acting Penfill
11 3Insulin Aspart Sanofi
12 1Insulin NovoNordisk NovoRapid
13 1Insulin NovoNordisk NovoRapid FlexPen
14 1Insulin NovoNordisk NovoRapid FlexTouch
15 1Insulin NovoNordisk NovoRapid Penfill
16 1Insulin NovoNordisk NovoRapid PumpCart Eml
17 2KIRSTY
18 2Kirsty
19 1MERILOG
20 1MERILOG SOLOSTAR
21 1NOVOLOG
22 1NOVOLOG FLEXPEN
23 1NOVOLOG FLEXTOUCH
24 1NOVOLOG INNOLET
25 1NOVOLOG MIX 50/50
26 1NOVOLOG MIX 70/30
27 1NOVOLOG MIX 70/30 FLEXPEN
28 2NOVOLOG MIX 70/30 PENFILL
29 1NOVOLOG PENFILL
30 2NOVOMIX 30
31 2NOVORAPID
32 1Novo rapid
33 1Novo rapid Flexpen
34 1Novo rapid Penfill
35 1Novo rapid pump the cart
36 2NovoMix 30
37 1NovoMix 30 FlexPen
38 1NovoMix 30 Penfill 3 mL
39 4NovoRapid
40 1NovoRapid FlexPen
41 1NovoRapid Penfill 3 mL
42 3Novomix
43 1Novomix 30 Flexpen
44 1Novomix 30 Novolet
45 1Novomix 30 Penfill
46 1Novomix 30 Penfill 100 E/ml
47 1Novomix 50 Flexpen
48 1Novomix 50 Penfill
49 1Novomix 70 Flexpen
50 1Novomix 70 Penfill
51 1Novomix Flexpen 30 100 E/ml
52 3Novorapid
53 3Novorapid Flexpen
54 1Novorapid Flextouch
55 1Novorapid Innolet
56 1Novorapid Novolet
57 2Novorapid Penfill
58 2Novorapid Pumpcart
59 1Novorapidfill
60 1RYZODEG 70/30
61 1Ryzodeg
62 1Ryzodeg FlexTouch
63 1Ryzodeg Flexpen
64 1Ryzodeg Flextouch
65 3Ryzodeg Penfill
66 3Ryzodeg®
67 3TRURAPI
68 2Truvelog Mix 30
01 7Australia
02 11Canada
03 6Italy
04 6Norway
05 10South Africa
06 9Spain
07 28Sweden
08 11Switzerland
09 17USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : MERILOG
Dosage Form : INJECTION;SOLUTION
Dosage Strength : 10ML(100UNITS/ML)
Packaging :
Approval Date :
Application Number : 761325
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : MERILOG SOLOSTAR
Dosage Form : INJECTION;SOLUTION
Dosage Strength : 3ML(100UNITS/ML)
Packaging :
Approval Date :
Application Number : 761325
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Injectable Solution
Dosage Strength : 100E/ml
Packaging :
Approval Date : 21/04/2021
Application Number : 20200727000046
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Solution For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/06/2020
Application Number : 20190604000057
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Solution For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/06/2020
Application Number : 20190604000064
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Insulin Aspart (Soluble); Insulin Aspart Protamine
Brand Name : Truvelog Mix 30
Dosage Form : Suspension For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/04/2022
Application Number : 20210429000121
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Insulin Aspart (Soluble); Insulin Aspart Protamine
Brand Name : Truvelog Mix 30
Dosage Form : Injectable Solution
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/04/2022
Application Number : 20210429000114
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506564
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506572
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2529254
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXPEN
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG INNOLET
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXTOUCH
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 FLEXPEN
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 50/50
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 50 UNITS/ML;50 UNITS/ML
Packaging :
Approval Date :
Application Number : 21810
Regulatory Info :
Registration Country : USA
Contact Us!
